retatrutide type 2 diabetes phase 2 lancet 2023 rosenstock What is ADA 2026: Retatrutide Revolution

But as these medications become more widely prescribed, patients are reporting an unexpected side effect: hair loss

A new view of diabetic retinopathy: a neurodegenerative disease of the eye

Keeping your digestive system running smoothly leads to a more comfortable and successful weight loss experience

Dysbiosis impairs incretin signaling, reducing the effectiveness of GLP-1 therapies

This has led to conceptualizing obesity as a chronic disease requiring ongoing management rather than a condition amenable to short-term cure

Initially, the average cost ranged around $1,000 per month, but prices are in flux and have dropped recently